Literature DB >> 21224065

Progranulin is a chemoattractant for microglia and stimulates their endocytic activity.

Fiona Pickford1, Jacob Marcus, Luiz Miguel Camargo, Qiurong Xiao, Danielle Graham, Jan-Rung Mo, Matthew Burkhardt, Vinayak Kulkarni, Jamie Crispino, Heike Hering, Michael Hutton.   

Abstract

Mutations resulting in progranulin haploinsufficiency cause disease in patients with a subset of frontotemporal lobar degeneration; however, the biological functions of progranulin in the brain remain unknown. To address this subject, the present study initially assessed changes in gene expression and cytokine secretion in rat primary cortical neurons treated with progranulin. Molecular pathways enriched in the progranulin gene set included cell adhesion and cell motility pathways and pathways involved in growth and development. Secretion of cytokines and several chemokines linked to chemoattraction but not inflammation were also increased from progranulin-treated primary neurons. Therefore, whether progranulin is involved in recruitment of immune cells in the brain was investigated. Localized lentiviral expression of progranulin in C57BL/6 mice resulted in an increase of Iba1-positive microglia around the injection site. Moreover, progranulin alone was sufficient to promote migration of primary mouse microglia in vitro. Primary microglia and C4B8 cells demonstrated more endocytosis of amyloid β1-42 when treated with progranulin. These data demonstrate that progranulin acts as a chemoattractant in the brain to recruit or activate microglia and can increase endocytosis of extracellular peptides such as amyloid β. Copyright Â
© 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21224065      PMCID: PMC3070582          DOI: 10.1016/j.ajpath.2010.11.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

1.  TRAIL is expressed in the brain cells of Alzheimer's disease patients.

Authors:  Daniela Uberti; Giuseppina Cantarella; Fabio Facchetti; Alessia Cafici; Giuseppe Grasso; Renato Bernardini; Maurizio Memo
Journal:  Neuroreport       Date:  2004-03-22       Impact factor: 1.837

2.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

3.  Rosetta error model for gene expression analysis.

Authors:  Lee Weng; Hongyue Dai; Yihui Zhan; Yudong He; Sergey B Stepaniants; Douglas E Bassett
Journal:  Bioinformatics       Date:  2006-03-07       Impact factor: 6.937

4.  Control of microglial neurotoxicity by the fractalkine receptor.

Authors:  Astrid E Cardona; Erik P Pioro; Margaret E Sasse; Volodymyr Kostenko; Sandra M Cardona; Ineke M Dijkstra; Deren Huang; Grahame Kidd; Stephen Dombrowski; RanJan Dutta; Jar-Chi Lee; Donald N Cook; Steffen Jung; Sergio A Lira; Dan R Littman; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2006-06-18       Impact factor: 24.884

5.  Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo.

Authors:  Z He; A Bateman
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

6.  Identification of a sex steroid-inducible gene in the neonatal rat hypothalamus.

Authors:  M Suzuki; S Yoshida; M Nishihara; M Takahashi
Journal:  Neurosci Lett       Date:  1998-02-20       Impact factor: 3.046

7.  Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex.

Authors:  Giada Monami; Eva M Gonzalez; Michelle Hellman; Leonard G Gomella; Raffaele Baffa; Renato V Iozzo; Andrea Morrione
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

8.  Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line.

Authors:  J Zhou; G Gao; J W Crabb; G Serrero
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

9.  Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains.

Authors:  V Bhandari; R G Palfree; A Bateman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

10.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.

Authors:  Matt Baker; Ian R Mackenzie; Stuart M Pickering-Brown; Jennifer Gass; Rosa Rademakers; Caroline Lindholm; Julie Snowden; Jennifer Adamson; A Dessa Sadovnick; Sara Rollinson; Ashley Cannon; Emily Dwosh; David Neary; Stacey Melquist; Anna Richardson; Dennis Dickson; Zdenek Berger; Jason Eriksen; Todd Robinson; Cynthia Zehr; Chad A Dickey; Richard Crook; Eileen McGowan; David Mann; Bradley Boeve; Howard Feldman; Mike Hutton
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

View more
  56 in total

1.  Functional genomic analyses identify pathways dysregulated by progranulin deficiency, implicating Wnt signaling.

Authors:  Ezra Y Rosen; Eric M Wexler; Revital Versano; Giovanni Coppola; Fuying Gao; Kellen D Winden; Michael C Oldham; Lauren Herl Martens; Ping Zhou; Robert V Farese; Daniel H Geschwind
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

Review 2.  Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment.

Authors:  Hyeon-Sook Suh; Benjamin B Gelman; Sunhee C Lee
Journal:  J Neuroimmune Pharmacol       Date:  2014-03       Impact factor: 4.147

Review 3.  Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.

Authors:  Deepti Lall; Robert H Baloh
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

Review 4.  Cellular effects of progranulin in health and disease.

Authors:  Louis De Muynck; Philip Van Damme
Journal:  J Mol Neurosci       Date:  2011-05-25       Impact factor: 3.444

5.  The Progranulin Cleavage Products, Granulins, Exacerbate TDP-43 Toxicity and Increase TDP-43 Levels.

Authors:  Dominique A Salazar; Victoria J Butler; Andrea R Argouarch; Tsung-Yuan Hsu; Amanda Mason; Ayumi Nakamura; Helen McCurdy; David Cox; Rachel Ng; Gloria Pan; William W Seeley; Bruce L Miller; Aimee W Kao
Journal:  J Neurosci       Date:  2015-06-24       Impact factor: 6.167

6.  Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4⁺ Foxp3⁺ regulatory T cells.

Authors:  Ya Hu; Haitao Xiao; Tingchen Shi; Joost J Oppenheim; Xin Chen
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 7.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

Review 8.  Innate immune activation in neurodegenerative disease.

Authors:  Michael T Heneka; Markus P Kummer; Eicke Latz
Journal:  Nat Rev Immunol       Date:  2014-07       Impact factor: 53.106

Review 9.  The Role of PGRN in Alzheimer's Disease.

Authors:  Hua Jing; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2015-07-28       Impact factor: 5.590

10.  Asymmetric pathology in primary progressive aphasia with progranulin mutations and TDP inclusions.

Authors:  Garam Kim; Saman S Ahmadian; Melanie Peterson; Zach Parton; Rohail Memon; Sandra Weintraub; Alfred Rademaker; Eileen Bigio; M-Marsel Mesulam; Changiz Geula
Journal:  Neurology       Date:  2016-01-20       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.